
Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.
BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, corresponding to a partial sequence originally identified in gastric juice. It is one of the more widely referenced synthetic peptide sequences in in-vitro laboratory literature owing to its defined structure and reported stability profile.
Every vial supplied by NXT GEN PEPTIDES is manufactured to strict laboratory standards, HPLC-characterised and independently third-party tested for identity and purity.
BPC-157 is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
At NXT GEN PEPTIDES, every batch of BPC-157 is HPLC-characterised and independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Store lyophilised at -20 °C. After reconstitution, store at 2–8 °C and use within 28 days.
This product is intended exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Triple agonist research peptide (GLP-1/GIP/glucagon).

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Bundle: BPC-157 10 mg and TB-500 10 mg supplied together at a research-lab discount.